0000899243-22-016310.txt : 20220503 0000899243-22-016310.hdr.sgml : 20220503 20220503162343 ACCESSION NUMBER: 0000899243-22-016310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220503 FILED AS OF DATE: 20220503 DATE AS OF CHANGE: 20220503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Topper James N CENTRAL INDEX KEY: 0001341382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 22887304 MAIL ADDRESS: STREET 1: 550 HAMILTON AVENUE, SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heron Patrick J CENTRAL INDEX KEY: 0001365617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 22887303 MAIL ADDRESS: STREET 1: 550 HAMILTON AVE., SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FHMLS X, L.L.C. CENTRAL INDEX KEY: 0001790811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 22887305 BUSINESS ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 621-7200 MAIL ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frazier Life Sciences X, L.P. CENTRAL INDEX KEY: 0001790879 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 22887307 BUSINESS ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 621-7200 MAIL ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FHMLS X, L.P. CENTRAL INDEX KEY: 0001790880 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 22887306 BUSINESS ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 621-7200 MAIL ADDRESS: STREET 1: 601 UNION STREET, SUITE 3200 STREET 2: TWO UNION SQUARE CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HilleVax, Inc. CENTRAL INDEX KEY: 0001888012 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE ST. STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: (617) 213-5054 MAIL ADDRESS: STREET 1: 75 STATE ST. STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-03 0 0001888012 HilleVax, Inc. HLVX 0001790879 Frazier Life Sciences X, L.P. 601 UNION STREET, SUITE 320 SEATTLE WA 98101 0 0 1 0 0001790880 FHMLS X, L.P. 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 0 0 1 0 0001790811 FHMLS X, L.L.C. 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 0 0 1 0 0001341382 Topper James N 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 0 0 1 0 0001365617 Heron Patrick J 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 1 0 1 0 Common Stock 2022-05-03 4 C 0 2736234 13.60 A 6770631 D Common Stock 2022-05-03 4 P 0 1764706 17.00 A 8535337 D Convertible Promissory Notes 13.60 2022-05-03 4 C 0 37212795.83 D Common Stock 2736234 0 D The securities are held directly by Frazer Life Sciences X, L.P. ("FLS X"). The general partner of FLS X is FHMLS X, L.P., and the general partner of FHMLS X, L.P. is FHMLS X, L.L.C. James Topper, M.D., Ph.D., and Patrick Heron are the sole managing members of FHMLS X, L.L.C. and share voting and investment power of the securities held by FLS X. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. The outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock immediately prior to the closing of the initial public offering at a conversion price of $13.60 per share. Frazier Life Sciences X, L.P., By: FHMLS X, L.P., its general partner, By: FHMLS X, L.L.C., its general partner, By: /s/ James N. Topper, Managing Director 2022-05-03 FHMLS X, L.P., By: FHMLS X, L.L.C., its general partner, By: /s/ James N. Topper, Managing Director 2022-05-03 FHMLS X, L.L.C., By: /s/ James N. Topper, Managing Director 2022-05-03 /s/ James N. Topper 2022-05-03 /s/ Patrick J. Heron 2022-05-03